Molecular and Cellular Mechanisms in Cardiovascular Dysfunction and Toxicity

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Cardiovascular System".

Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 5176

Special Issue Editors


E-Mail Website
Guest Editor
UMR-S 942, INSERM, 75010 Paris, France
Interests: cardiac dysfunction; bio-therapy; cardio-oncology; biomarker; pathophysiology; cardio-circulatory failure

E-Mail Website
Guest Editor
INSERM, CHU Lille, Institut Pasteur de Lille, University of Lille, U1167—RID-AGE—Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement, F-59000 Lille, France
Interests: cardiac dysfunction; metabolism; oxidative stress; post-translational modification; pathophysiology

Special Issue Information

Dear Colleagues,

Cardiovascular diseases are a leading cause of death worldwide. This issue will focus on known and new, shared and specific, signaling pathways leading to the large spectrum of cardiovascular diseases among which are heart failure, myocardial infarction, hypertension and genetic or reversible cardiomyopathies. Mechanisms of cardiac toxicity occurring as a side effect of chemotherapy and radiotherapy will also be highlighted in this Special Issue.

This Special Issue deals with abnormalities in cardiomyocytes contraction and relaxation including calcium handling, mitochondria and energy homeostasis, oxidative stress and cardiac cells survival and apoptosis, extracellular matrix, cell micro-environment and cell-cell crosstalk. Studies on alteration of hormonal and neurohormonal signaling including adrenergic system, renin–angiotensin–aldosterone system alongside with sex hormones leading to cardiac dysfunction or toxicity will be included in this issue.

This Special Issue aims to provide a better understanding of molecular and cellular mechanisms leading to cardiac damage, that are still not well understood. Furthermore, our aim is to gain a general overview of known and new therapeutic approaches and drug targets in the field.

Dr. Feriel Azibani
Dr. Emilie Dubois-Deruy
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mitochondria
  • oxidative stress
  • chemotherapy
  • cell survival
  • cytokines
  • cardiomyocyte
  • fibrosis
  • calcium handling

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 1434 KiB  
Review
Pathophysiological Roles of the TRPV4 Channel in the Heart
by Sébastien Chaigne, Solène Barbeau, Thomas Ducret, Romain Guinamard and David Benoist
Cells 2023, 12(12), 1654; https://doi.org/10.3390/cells12121654 - 17 Jun 2023
Cited by 16 | Viewed by 4770
Abstract
The transient receptor potential vanilloid 4 (TRPV4) channel is a non-selective cation channel that is mostly permeable to calcium (Ca2+), which participates in intracellular Ca2+ handling in cardiac cells. It is widely expressed through the body and is activated by [...] Read more.
The transient receptor potential vanilloid 4 (TRPV4) channel is a non-selective cation channel that is mostly permeable to calcium (Ca2+), which participates in intracellular Ca2+ handling in cardiac cells. It is widely expressed through the body and is activated by a large spectrum of physicochemical stimuli, conferring it a role in a variety of sensorial and physiological functions. Within the cardiovascular system, TRPV4 expression is reported in cardiomyocytes, endothelial cells (ECs) and smooth muscle cells (SMCs), where it modulates mitochondrial activity, Ca2+ homeostasis, cardiomyocytes electrical activity and contractility, cardiac embryonic development and fibroblast proliferation, as well as vascular permeability, dilatation and constriction. On the other hand, TRPV4 channels participate in several cardiac pathological processes such as the development of cardiac fibrosis, hypertrophy, ischemia–reperfusion injuries, heart failure, myocardial infarction and arrhythmia. In this manuscript, we provide an overview of TRPV4 channel implications in cardiac physiology and discuss the potential of the TRPV4 channel as a therapeutic target against cardiovascular diseases. Full article
Show Figures

Figure 1

Back to TopTop